TheFOXE1locus is a major genetic determinant for familial nonmedullary thyroid carcinoma-Reference-Cited by-同舟云学术

TheFOXE1locus is a major genetic determinant for familial nonmedullary thyroid carcinoma

Published:2013-10-31 Issue:9 Volume:134 Page:2098-2107
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bonora Elena¹,Rizzato Cosmeri²,Diquigiovanni Chiara¹,Oudot-Mellakh Tiphaine³,Campa Daniele²,Vargiolu Manuela⁴,Guedj Mickaël⁵,McKay James D.⁶,Romeo Giovanni¹,Canzian Federico²,Lesueur Fabienne⁶⁷,

Affiliation:

1. Unit of Medical Genetics Department of Medical and Surgical Sciences; University of Bologna; Bologna Italy

2. Genomic Epidemiology Group; German Cancer Research Center (DKFZ); Heidelberg Germany

3. INSERM U945 Faculté de Médecine Pitié-Salpêtrière; Paris France

4. Health Sciences and Technologies Interdepartmental Center for Industrial Research; University of Bologna; Bologna Italy

5. Department of Biostatistics; Pharnext; Paris France

6. Genetic Cancer Susceptibility, International Agency for Research on Cancer (IARC), Lyon; France

7. INSERM, U900, Institut Curie, Mines ParisTech, 26 rue d'Ulm, 75248 Paris cedex 05; France

Funder

FP6 EU grant

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Papillary and follicular thyroid carcinoma;Schlumberger;N Engl J Med,1998

2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

3. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands;Goldgar;J Natl Cancer Inst,1994

4. Effect of paternal and maternal cancer on cancer in the offspring: a population-based study;Hemminki;Cancer Epidemiol Biomarkers Prev,1997

5. Familial nonmedullary thyroid carcinoma-the case for genetic susceptibility;Fagin;J Clin Endocrinol Metab,1997

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of P21 (CDKN1A) Activated Kinase 4 as a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma;Thyroid®;2024-05-01

2. Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer;Frontiers in Oncology;2024-03-20

3. Genetic susceptibility to hereditary non-medullary thyroid cancer;Hereditary Cancer in Clinical Practice;2022-03-07

4. Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes;Endocrine Pathology;2022-03

5. Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys;Frontiers in Endocrinology;2022-02-28